Oscar Illescas Pomposo

Dr. Oscar Illescas Pomposo

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
OPOscar Illescas Pomposo
Oscar Illescas Pomposo
MRMiriam Rodríguez-Sosa
Miriam Rodríguez-Sosa
MGmanuela gariboldi
manuela gariboldi
Gut microbiota dysbiosis is a common feature in colorectal cancer (CRC) and inflammatory bowel diseases (IBD). Adoption of the Mediterranean diet (MD) has been proposed as a therapeutic approach for the prevention of multiple diseases, and one of its mechanisms of action is the modulation of the microbiota. We aimed to determine whether MD can be used as a preventive measure against cancer and inflammation-related diseases of the gut, based on its capacity to modulate the local microbiota. A joint meta-analysis of publicly available 16S data derived from subjects following MD or other diets and from patients with CRC, IBD, or other gut-related diseases was conducted. We observed that the microbiota associated with MD was enriched in bacteria that promote an anti-inflammatory environment but low in taxa with pro-inflammatory properties capable of altering intestinal barrier functions. We found an opposite trend in patients with intestinal diseases, including cancer. Some of these differences were maintained even when MD was compared to healthy controls without a defined diet. Our findings highlight the unique effects of MD on the gut microbiota and suggest that integrating MD principles into a person’s lifestyle may serve as a preventive method against cancer and other gut-related diseases.

1 March 2018 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
OPOscar Illescas Pomposo
Oscar Illescas Pomposo
CVCarlos Verjan
Carlos Verjan
LGLizbeth García-Velázquez
Lizbeth García-Velázquez
TGTzipe Govezensky
Tzipe Govezensky
Miriam Rodriguez-SosaMiriam Rodriguez-Sosa
Miriam Rodriguez-Sosa
Human macrophage migration inhibitory factor (MIF) is a cytokine that plays a role in several metabolic and inflammatory processes. Single nucleotide polymorphism (SNP) -173 G/C (rs755622) on MIF gene has been associated with numerous diseases, such as arthritis and cancer. However, most of the reports concerning the association of MIF with these and other pathologies are inconsistent and remain quite controversial. Therefore, we performed a meta-analysis from 96 case-control studies on -173 G/C MIF SNP and stratified the data according to the subjects geographic localization or the disease pathophysiology, in order to determine a more meaningful significance to this SNP. The polymorphism was strongly associated with an increased risk in autoimmune-inflammatory, infectious and age-related diseases on the dominant (OR: 0.74 [0.58–0.93], P < 0.01; OR: 0.81 [0.74–0.89], P < 0.0001; and OR: 0.81 [0.76–0.87], P < 0.0001, respectively) and the recessive models (OR: 0.74 [0.57–0.095], P < 0.01; OR: 0.66 [0.48–0.92], P < 0.0154; and OR: 0.70 [0.60–0.82], P < 0.0001, respectively). Also, significant association was found in the geographic localization setting for Asia, Europe and Latin America subdivisions in the dominant (OR: 0.76 [0.69–0.84], P < 0.0001; OR: 0.77 [0.72–0.83], P < 0.0001; OR: 0.61 [0.44–0.83], P-value: 0.0017, respectively) and overdominant models (OR: 0.85 [0.77–0.94], P < 0.0001; OR: 0.80 [0.75–0.86], P < 0.0001; OR: 0.73 [0.63–0.85], P-value: 0.0017, respectively). Afterwards, we implemented a network meta-analysis to compare the association of the polymorphism for two different subdivisions. We found a stronger association for autoimmune than for age-related or autoimmune-inflammatory diseases, and stronger association for infectious than for autoimmune-inflammatory diseases. We report for the first time a meta-analysis of rs755622 polymorphism with a variety of stratified diseases and populations. The study reveals a strong association of the polymorphism with autoimmune and infectious diseases. These results may help direct future research on MIF-173 G/C in diseases in which the relation is clearer and thus assist the search for more plausible applications.

10 July 2019 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
TPThalia Pacheco-Fernandez
Thalia Pacheco-Fernandez
IJImelda Juárez-Avelar
Imelda Juárez-Avelar
OPOscar Illescas Pomposo
Oscar Illescas Pomposo
Luis I TerrazasLuis I Terrazas
Luis I Terrazas
RHRogelio Hernández-Pando
Rogelio Hernández-Pando
Miriam Rodriguez-SosaMiriam Rodriguez-Sosa
Miriam Rodriguez-Sosa
Colitis-associated colorectal cancer (CRC) development has been shown to be related to chronically enhanced inflammation. Macrophage migration inhibitory factor (MIF) is an inflammatory mediator that favors inflammatory cytokine production and has chemotactic properties for the recruitment of macrophages (Møs) and T cells. Here, we investigated the role of MIF in the inflammatory response and recruitment of immune cells in a murine model of chemical carcinogenesis to establish the impact of MIF on CRC genesis and malignancy. We used BALB/c MIF-knockout (MIF-/-) and wild-type (WT) mice to develop CRC by administering intraperitoneal (i.p.) azoxymethane and dextran sodium sulfate in drinking water. Greater tumor burdens were observed in MIF-/-mice than in WT mice. Tumors from MIF-/-mice were histologically identified to be more aggressive than tumors from WT mice. The localization of MIF suggests that it is also involved in cell differentiation. The relative gene expression ofil-17, measured by real-time PCR, was higher in MIF-/-CRC mice, compared to the WT CRC and healthy MIF-/-mice. Importantly, compared to the WT intestinal epithelium, lower percentages of tumor-associated Møs were found in the MIF-/-intestinal epithelium. These results suggest that MIF plays a role in controlling the initial development of CRC by attracting Møs to the tumor, which is a condition that favors the initial antitumor responses.

1 September 2020 in Cytokine
Verified
Journal Article
Closed access
OPOscar Illescas Pomposo
Oscar Illescas Pomposo
OPOscar Illescas Pomposo
Oscar Illescas Pomposo
TPThalia Pacheco-Fernandez
Thalia Pacheco-Fernandez
JLJuan P. Laclette
Juan P. Laclette
TRTonathiu Rodriguez
Tonathiu Rodriguez
Miriam Rodriguez-SosaMiriam Rodriguez-Sosa
Miriam Rodriguez-Sosa

1 December 2012 in Molecular and Biochemical Parasitology
Verified
Journal Article
Closed access
OPOscar Illescas Pomposo
Oscar Illescas Pomposo
JCJulio C. Carrero
Julio C. Carrero
RBRaúl J. Bobes
Raúl J. Bobes
AFAna Flisser
Ana Flisser
GRGabriela Rosas
Gabriela Rosas
JLJuan P. Laclette
Juan P. Laclette

20 May 2011 in Pharmaceutical Biology
Verified
Journal Article
Closed access
PDF file
MAMaría I. Aguilar
María I. Aguilar
RRRicardo Rovelo
Ricardo Rovelo
CVCarlos Verjan
Carlos Verjan
OPOscar Illescas Pomposo
Oscar Illescas Pomposo
ABAna E. Baeza
Ana E. Baeza
ANAndrés Navarrete
Andrés Navarrete
Context: The main use of stem bark infusions of Alnus acuminata ssp. arguta (Schlecht.) Furlow (Betulaceae) includes treatments for acute inflammation in Mexican traditional medicine. Objective: n-Hexane (CHE), chloroform (CCE), and methanol (CME) extracts of the stem bark were investigated for anti-inflammatory activity and its safety. Materials and methods: The anti-inflammatory effects of the orally administered CME, CCE, and CHE extracts, using carrageenan-induced rat hind paw edema model, and acute oral toxicity in mice, using Lorke’s method, were determined. Results and discussion: The column chromatographic fraction (CME-3) showed a higher anti-inflammatory activity (92.2%) (IC50: 60.8 mg/mL) as compared with CME (76.9%); both were in the same order of magnitude as that of indomethacin, the positive control drug. Safety parameters for acute oral toxicity test showed that CME was not toxic (LD50: >5000). Several triterpenoids (1–7) from hexane extracts and diarylheptanoids (10–14) from methanol extracts of A. acuminata ssp. arguta were isolated and characterized. Conclusions: These results confirm the traditional uses of A. acuminata in acute inflammatory conditions and its safety for consumption.